Your browser doesn't support javascript.
loading
Well-functioning bicuspid aortic valves should be preserved during aortic replacement for the ascending aortopathy phenotype.
Roselli, Eric E; Thompson, Matthew A; Yazdchi, Farhang; Lowry, Ashley; Johnston, Douglas R; Desai, Milind; Blackstone, Eugene H.
Afiliação
  • Roselli EE; Aorta Center, Cleveland, Ohio; Bicuspid Aortic Valve Center, Cleveland, Ohio; Department of Thoracic and Cardiovascular Surgery, Cleveland, Ohio. Electronic address: RosellE@ccf.org.
  • Thompson MA; Department of Thoracic and Cardiovascular Surgery, Cleveland, Ohio; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.
  • Yazdchi F; Department of Cardiac Surgery, Brigham and Women's Hospital, Boston, Mass.
  • Lowry A; Aorta Center, Cleveland, Ohio; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
  • Johnston DR; Aorta Center, Cleveland, Ohio; Bicuspid Aortic Valve Center, Cleveland, Ohio; Department of Thoracic and Cardiovascular Surgery, Cleveland, Ohio.
  • Desai M; Aorta Center, Cleveland, Ohio; Bicuspid Aortic Valve Center, Cleveland, Ohio; Department of Cardiology, Heart, Vascular, and Thoracic Institute, Cleveland, Ohio.
  • Blackstone EH; Department of Thoracic and Cardiovascular Surgery, Cleveland, Ohio; Department of Cardiac Surgery, Brigham and Women's Hospital, Boston, Mass.
Article em En | MEDLINE | ID: mdl-35961879
ABSTRACT

OBJECTIVES:

Consensus has not been reached on whether or not to replace or preserve a well-functioning bicuspid aortic valve (BAV) in patients undergoing aortic replacement for the ascending phenotype of BAV aortopathy. We characterize morphology, evaluate progression of aortic regurgitation or aortic stenosis, and investigate the need for aortic valve replacement in patients whose well-functioning BAV was preserved during ascending aortic replacement ≥10 years prior.

METHODS:

From January 1991 to August 2011, 191 patients with a well-functioning BAV underwent supracoronary aortic replacement (113 valves were minimally repaired). Aortic morphology was evaluated, aortic regurgitation grade and transvalvular aortic gradient modeled parametrically, and survival assessed by the Kaplan-Meier method. Median follow-up was 10 years.

RESULTS:

Mean aortic diameter was 2.9 ± 0.53 cm at the annulus and 4.2 ± 0.55 cm at the sinuses. Mean maximum ascending diameter was 5.1 ± 0.49 cm. All patients exhibited a cusp-fusion BAV phenotype. Fifteen-year progression to severe aortic regurgitation was 3.2%. Mean aortic valve gradient began to rise 5 years postoperatively to 27 mm Hg by 14 years. Freedom from aortic valve replacement at 1, 5, 10, and 15 years was 100%, 95%, 83%, and 63%, respectively. Minimal valve repair was not associated with late aortic valve replacement. Fifteen-year survival was 74%.

CONCLUSIONS:

Preserving a well-functioning BAV should be considered in carefully selected patients undergoing aortic replacement for the ascending phenotype of BAV aortopathy. The valves remain durable in the long term, with slow progression of regurgitation or stenosis, and low probability of aortic valve replacement through 10 years.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article